Telmital-Beta 50 Tablet ER
Marketer
Talent India
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (50mg)
Overview Telmital-Beta 50 Tablet ER
Beta-Tel 50 Extended-Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use improves heart attack survival rates. For consistent blood levels, take this medication with food daily, as directed by your physician. Continue treatment as prescribed; high blood pressure is often asymptomatic, and discontinuation can worsen your condition. Lifestyle modifications, including exercise, weight management, and a healthy diet, complement this therapy. Follow your doctor's instructions carefully. Potential side effects include headache, weakness, dizziness, hypotension (possibly with fainting), shortness of breath, nausea, vomiting, abdominal pain, fatigue, and elevated potassium. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be required. Inform your doctor of any kidney or liver issues before starting this medication. Pregnant or breastfeeding individuals should consult their physician. Disclose all medications, particularly those for hypertension or cardiac conditions.
Primary Ingredients of Telmital-Beta 50 Tablet ER
No text was provided to rewrite.
Uses of Telmital-Beta 50 Tablet ER
Managing Elevated Blood Pressure
Major Benefits of Telmital-Beta 50 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telmital-Beta 50 Extended-Release tablets should be administered with a meal.
Common Side effects of Telmital-Beta 50 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Telmital-Beta 50 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Telmital-Beta 50 Tablet ER with a meal.
How Telmital-Beta 50 Tablet ER works:
Telmisartan and Metoprolol Succinate, combined in Telmital-Beta 50 ER tablets, provide sustained-release hypertension treatment.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Telmital-Beta 50 Tablet ER use poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Extended-release Telmital-Beta 50mg tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Telmital-Beta 50mg tablets are likely safe for use while breastfeeding. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Telmital-Beta 50 mg tablets can reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Telmital-Beta 50 tablets are considered safe for patients with renal impairment. No dosage modification is necessary for this medication in such patients.
LiverCAUTION
Extended-release Telmital-Beta 50 tablets require careful administration for individuals with hepatic impairment. Dosage modification might be necessary. Physician consultation is advised.
What if you forget to take Telmital-Beta 50 Tablet ER :
Should you forget a Telmital-Beta 50 Tablet ER dose, take it immediately upon remembering. If, however, your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telmital-Beta 50 Tablet ER
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | HEART |



